Experiment: 7Z3C

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	3D 1H-15N NOESY	1 mM [U-100% 13C; U-100% 15N] GYF	90% H2O/10% D2O	0.1 mM	7	1 atm	303	Bruker AVANCE III 600
2	3D 1H-13C NOESY	1 mM [U-100% 13C; U-100% 15N] GYF	90% H2O/10% D2O	0.1 mM	7	1 atm	303	Bruker AVANCE III 600
3	3D 1H-13C NOESY aliphatic	1 mM [U-100% 13C; U-100% 15N] GYF	90% H2O/10% D2O	0.1 mM	7	1 atm	303	Bruker AVANCE III 600
4	3D 1H-13C NOESY aromatic	1 mM [U-100% 13C; U-100% 15N] GYF	90% H2O/10% D2O	0.1 mM	7	1 atm	303	Bruker AVANCE III 600
5	2D 1H-15N HSQC	1 mM [U-100% 13C; U-100% 15N] GYF	90% H2O/10% D2O	0.1 mM	7	1 atm	303	Bruker AVANCE III 600

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III	600

NMR Refinement
Method	Details	Software
simulated annealing		Amber

NMR Ensemble Information
Conformer Selection Criteria	target function
Conformers Calculated Total Number	100
Conformers Submitted Total Number	19
Representative Model	1 (medoid)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	refinement	Amber		Case, Darden, Cheatham III, Simmerling, Wang, Duke, Luo, ... and Kollman
2	structure calculation	CYANA		Guntert, Mumenthaler and Wuthrich
3	chemical shift assignment	CcpNmr Analysis		CCPN
4	peak picking	CcpNmr Analysis		CCPN

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.